You might be interested in
Health & Biotech
ASX Health Winners January: 'Invest in business not science', as SHG and PAA top winners list
Health & Biotech
ASX Health Stocks: EMvision calls its AI brain scanner 'emu'
Health & Biotech
Here’s our fortnightly wrap of all the news driving ASX health stocks.
Of the ASX’s 134-odd small cap health stocks, 51 saw their share prices fall, 73 improved and 15 were flat.
The top mover was G Medical (ASX:GMV), which has finally begun following through on long delayed deals, and this has been reflected in its share price.
The company completed the clinical trials required to obtain National Medical Products Administration (NMPA) approval for the use of its Prizma device in China.
It’s also secured Taiwan Food and Drug Administration approval, and partner First Channel has until April 4 to provide ancillary Prizma product information such as packaging and labelling to allow it to collect the licence.
G Medical announced deals in 2017 with several distribution partners for the Prizma device that forecast more than $US168m ($245.5m) worth of revenue in the first year of operation.
But delays in getting Chinese manufacturing approval and then doing the requisite clinical trials needed to have a product approved in that country led to the ASX in October asking when, if ever, investors might see this money.
The Silverlake deal for China and the MEDTL deal for Cyprus relied on regulatory approval in China for manufacturing.
First Channel was to supply India and Taiwan and was reliant on finding appropriate partners.
G Medical said at the time all agreements were still current.
Code | Name | Price (Jan 22) | 2 week return % | 1 year return % | Market cap |
---|---|---|---|---|---|
GMV | G MEDICAL INNOVATION HOLDING | 0.155 | 85 | -43 | $63,381,604 |
GTG | GENETIC TECHNOLOGIES LTD | 0.01 | 67 | 34 | $40,631,340 |
CAN | CANN GROUP LTD | 1.54 | 61 | -31 | $219,329,984 |
MDR | MEDADVISOR LTD | 0.57 | 61 | 120 | $140,186,400 |
EXL | ELIXINOL GLOBAL LTD | 1.135 | 53 | -60 | $156,509,824 |
BXN | BIOXYNE LTD | 0.02 | 33 | -26 | $12,802,908 |
ANR | ANATARA LIFESCIENCES LTD | 0.335 | 26 | -22 | $16,701,819 |
PNV | POLYNOVO LTD | 2.55 | 26 | 315 | $1,685,774,464 |
IHL | IMPRESSION HEALTHCARE LTD | 0.075 | 25 | 257 | $53,056,196 |
NC6 | NANOLLOSE LTD | 0.065 | 25 | -46 | $4,875,000 |
AVE | AVECHO BIOTECHNOLOGY LTD | 0.005 | 25 | 25 | $7,887,287 |
SKN | SKIN ELEMENTS LTD | 0.016 | 23 | -36 | $2,599,421 |
UCM | USCOM LTD | 0.14 | 22 | 0 | $20,928,302 |
SCU | STEMCELL UNITED LTD | 0.017 | 21 | -23 | $10,907,342 |
AC8 | AUSCANN GROUP HOLDINGS LTD | 0.35 | 21 | -50 | $110,966,576 |
ATX | AMPLIA THERAPEUTICS LTD | 0.08 | 19 | -43 | $4,253,647 |
PAR | PARADIGM BIOPHARMACEUTICALS | 3.66 | 18 | 226 | $723,889,792 |
AVH | AVITA MEDICAL LTD | 0.735 | 18 | 513 | $1,556,343,552 |
FTT | FACTOR THERAPEUTICS LTD | 0.0035 | 17 | 75 | $3,649,925 |
MDC | MEDLAB CLINICAL LTD | 0.36 | 16 | -10 | $83,959,848 |
RAP | RESAPP HEALTH LTD | 0.3 | 15 | 200 | $208,876,656 |
ESE | ESENSE-LAB LTD-CDI | 0.015 | 15 | -46 | $2,851,154 |
NXS | NEXT SCIENCE LTD | 2.24 | 15 | $403,335,200 | |
ADO | ANTEOTECH LTD | 0.031 | 15 | 91 | $46,323,528 |
BLT | BENITEC BIOPHARMA LTD | 0.04 | 14 | -60 | $12,851,481 |
M7T | MACH7 TECHNOLOGIES LTD | 0.76 | 14 | 280 | $138,838,672 |
OPT | OPTHEA LTD | 3.37 | 14 | 341 | $907,061,696 |
ADR | ADHERIUM LTD | 0.033 | 14 | -3 | $6,470,043 |
ALC | ALCIDION GROUP LTD | 0.21 | 14 | 367 | $208,045,744 |
LSH | LIFESPOT HEALTH LTD | 0.034 | 13 | -55 | $2,637,335 |
CPH | CRESO PHARMA LTD | 0.185 | 12 | -66 | $32,211,692 |
MXC | MGC PHARMACEUTICALS LTD | 0.038 | 12 | -5 | $52,102,664 |
THC | THC GLOBAL GROUP LTD | 0.43 | 12 | -11 | $60,530,904 |
IMM | IMMUTEP LTD | 0.295 | 11 | -7 | $115,531,128 |
ZLD | ZELIRA THERAPEUTICS LTD | 0.061 | 11 | 9 | $53,219,036 |
PAB | PATRYS LTD | 0.021 | 11 | -13 | $22,524,396 |
NEU | NEUREN PHARMACEUTICALS LTD | 2.83 | 10 | 102 | $291,971,168 |
IDT | IDT AUSTRALIA LTD | 0.165 | 10 | 14 | $39,097,268 |
CGS | COGSTATE LTD | 0.5 | 10 | -16 | $84,127,496 |
IPD | IMPEDIMED LTD | 0.17 | 10 | -14 | $86,878,384 |
BIT | BIOTRON LTD | 0.06 | 9 | -52 | $42,115,964 |
SDX | SIENNA CANCER DIAGNOSTICS LT | 0.04 | 8 | -33 | $15,805,314 |
AHX | APIAM ANIMAL HEALTH LTD | 0.47 | 8 | 1 | $54,465,668 |
PIQ | PROTEOMICS INTERNATIONAL LAB | 0.3 | 7 | -20 | $27,564,262 |
TDL | TBG DIAGNOSTICS LTD | 0.032 | 7 | -27 | $6,962,793 |
CP1 | CANNPAL ANIMAL THERAPEUTICS | 0.16 | 7 | 23 | $14,900,000 |
OSL | ONCOSIL MEDICAL LTD | 0.17 | 6 | -6 | $107,220,496 |
PBP | PROBIOTEC LTD | 2.15 | 6 | 46 | $160,774,576 |
GSS | GENETIC SIGNATURES LTD | 1.02 | 6 | 29 | $145,171,248 |
MEM | MEMPHASYS LTD | 0.056 | 6 | 84 | $42,222,536 |
LCT | LIVING CELL TECHNOLOGIES LTD | 0.019 | 6 | -60 | $10,857,379 |
MVP | MEDICAL DEVELOPMENTS INTERNA | 9.33 | 5 | 135 | $612,115,840 |
ATH | ALTERITY THERAPEUTICS LTD | 0.02 | 5 | -46 | $17,847,400 |
PYC | PYC THERAPEUTICS LTD | 0.065 | 5 | 132 | $190,542,816 |
HLA | HEALTHIA LTD | 1.13 | 5 | 5 | $71,229,160 |
TD1 | TALI DIGITAL LTD | 0.05 | 4 | 61 | $37,465,260 |
SDI | SDI LTD | 0.885 | 4 | 43 | $105,195,992 |
DVL | DORSAVI LTD | 0.027 | 4 | -58 | $5,888,543 |
DXB | DIMERIX LTD | 0.14 | 4 | 61 | $25,413,740 |
CDX | CARDIEX LTD | 0.029 | 4 | -42 | $21,843,070 |
ICS | ICSGLOBAL LTD | 1.905 | 4 | 121 | $20,200,656 |
AGH | ALTHEA GROUP HOLDINGS LTD | 0.465 | 3 | 66 | $108,489,152 |
MMJ | MMJ GROUP HOLDINGS LTD | 0.155 | 3 | -40 | $34,781,844 |
OCC | ORTHOCELL LTD | 0.49 | 3 | 250 | $90,333,832 |
ACW | ACTINOGEN MEDICAL LTD | 0.037 | 3 | -36 | $41,411,560 |
1ST | 1ST GROUP LTD | 0.08 | 3 | 220 | $33,969,352 |
CDY | CELLMID LTD | 0.23 | 2 | -16 | $22,217,280 |
RAC | RACE ONCOLOGY LTD | 0.23 | 2 | 153 | $25,103,328 |
CYC | CYCLOPHARM LTD | 1.3 | 2 | 17 | $101,709,920 |
CTE | CRYOSITE LTD | 0.054 | 2 | 20 | $2,530,417 |
SUD | SUDA PHARMACEUTICALS LTD | 0.06 | 2 | -49 | $8,535,264 |
HCT | HOLISTA COLLTECH LTD | 0.08 | 1 | 38 | $18,753,926 |
NVL | NATIONAL VETERINARY CARE LTD | 3.66 | 1 | 105 | $245,738,352 |
KZA | KAZIA THERAPEUTICS LTD | 0.625 | 1 | 49 | $45,104,172 |
PSQ | PACIFIC SMILES GROUP LTD | 1.76 | 1 | 35 | $267,508,368 |
CYP | CYNATA THERAPEUTICS LTD | 1.2 | 0 | -11 | $123,621,784 |
CAJ | CAPITOL HEALTH LTD | 0.23 | 0 | -7 | $176,731,872 |
MEB | MEDIBIO LTD | 0.01 | 0 | -47 | $9,951,300 |
ALT | ANALYTICA LTD | 0.003 | 0 | -40 | $10,558,837 |
BPH | BPH ENERGY LTD | 0.001 | 0 | -33 | $3,341,463 |
GLH | GLOBAL HEALTH LTD | 0.145 | 0 | -14 | $6,104,257 |
JHL | JAYEX HEALTHCARE LTD | 0.03 | 0 | 11 | $5,178,391 |
ONE | ONEVIEW HEALTHCARE PLC-CDI | 0.12 | 0 | -77 | $20,785,378 |
IMU | IMUGENE LTD | 0.035 | 0 | 75 | $154,908,976 |
ONT | 1300 SMILES LTD | 6.1 | 0 | 2 | $144,438,144 |
JHC | JAPARA HEALTHCARE LTD | 0.995 | -1 | -10 | $265,911,088 |
MVF | MONASH IVF GROUP LTD | 1.02 | -1 | 15 | $240,501,600 |
PGC | PARAGON CARE LTD | 0.43 | -1 | -25 | $145,290,672 |
RCE | RECCE PHARMACEUTICALS LTD | 0.36 | -1 | 140 | $48,335,060 |
AZV | AZURE HEALTHCARE LTD | 0.083 | -2 | 46 | $23,587,682 |
AMT | ALLEGRA ORTHOPAEDICS LTD | 0.2 | -2 | 0 | $19,911,810 |
ELX | ELLEX MEDICAL LASERS LTD | 0.76 | -3 | 27 | $109,136,864 |
ACR | ACRUX LTD | 0.18 | -3 | -10 | $30,040,040 |
KKT | KONEKT LTD | 0.65 | -3 | 159 | |
SOM | SOMNOMED LTD | 2.77 | -3 | 53 | $173,967,552 |
MX1 | MICRO-X LTD | 0.165 | -3 | -38 | $41,253,376 |
PAA | PHARMAUST LTD | 0.091 | -3 | 139 | $27,483,916 |
IMC | IMMURON LTD | 0.13 | -4 | -48 | $23,038,392 |
VHT | VOLPARA HEALTH TECHNOLOGIES | 1.79 | -4 | 45 | $390,792,768 |
RHT | RESONANCE HEALTH LTD | 0.25 | -4 | 153 | $107,720,984 |
BWX | BWX LTD | 4.31 | -4 | 177 | $535,517,024 |
S66 | STAR COMBO PHARMA LTD | 0.46 | -4 | -17 | $39,806,836 |
EHH | EAGLE HEALTH HOLDINGS LTD | 0.115 | -4 | -41 | $38,365,908 |
RNO | RHINOMED LTD | 0.18 | -5 | -18 | $30,457,082 |
RGS | REGENEUS LTD | 0.072 | -5 | -54 | $20,003,400 |
PAL | PALLA PHARMA LTD | 1.005 | -6 | -14 | $126,577,720 |
BD1 | BARD1 LIFE SCIENCES LTD | 0.032 | -6 | 40 | $43,749,920 |
NTI | NEUROTECH INTERNATIONAL LTD | 0.016 | -6 | -61 | $2,171,902 |
LBT | LBT INNOVATIONS LTD | 0.16 | -6 | 88 | $37,686,364 |
PTX | PRESCIENT THERAPEUTICS LTD | 0.056 | -7 | -17 | $22,078,596 |
VBS | VECTUS BIOSYSTEMS LTD | 0.55 | -7 | 10 | $13,010,149 |
TLX | TELIX PHARMACEUTICALS LTD | 1.49 | -7 | 96 | $377,387,200 |
PXS | PHARMAXIS LTD | 0.135 | -7 | -50 | $53,280,748 |
OSP | OSPREY MEDICAL INC-CDI | 0.027 | -7 | -77 | $11,658,529 |
BOT | BOTANIX PHARMACEUTICALS LTD | 0.093 | -7 | 21 | $90,460,920 |
OSX | OSTEOPORE LTD | 0.66 | -7 | $66,812,132 | |
OIL | OPTISCAN IMAGING LTD | 0.036 | -8 | -18 | $17,200,036 |
UBI | UNIVERSAL BIOSENSORS INC-CDI | 0.17 | -8 | -23 | $30,166,676 |
APH | AUSTRALIAN PRIMARY HEMP LTD | 0.165 | -8 | 3 | $11,472,472 |
IVX | INVION LTD | 0.011 | -8 | -39 | $60,506,668 |
VLS | VITA LIFE SCIENCES LTD | 0.65 | -8 | -16 | $36,131,716 |
ANP | ANTISENSE THERAPEUTICS LTD | 0.075 | -9 | 108 | $36,658,896 |
IBX | IMAGION BIOSYSTEMS LTD | 0.03 | -9 | -6 | $15,338,466 |
BNO | BIONOMICS LTD | 0.077 | -9 | -38 | $41,940,812 |
FFC | FARMAFORCE LTD | 0.09 | -10 | -25 | $11,589,388 |
RSH | RESPIRI LTD | 0.08 | -10 | -8 | $44,500,648 |
PCK | PAINCHEK LTD | 0.175 | -10 | 430 | $181,216,416 |
NOX | NOXOPHARM LTD | 0.255 | -11 | -45 | $33,711,048 |
CMP | COMPUMEDICS LTD | 0.7 | -11 | 106 | $124,014,064 |
SVA | SIMAVITA LTD-CDI | 0.03 | -12 | 58 | $12,533,344 |
1AD | ADALTA LTD | 0.095 | -14 | -59 | $15,574,833 |
OVN | OVENTUS MEDICAL LTD | 0.425 | -15 | 41 | $55,475,128 |
NSB | NEUROSCIENTIFIC BIOPHARMACEU | 0.165 | -15 | 14 | $12,933,456 |
RHY | RHYTHM BIOSCIENCES LTD | 0.105 | -16 | -22 | $10,578,750 |
VTI | VISIONEERING TECH-CDI | 0.041 | -16 | -77 | $19,097,874 |
SIL | SMILES INCLUSIVE LTD | 0.052 | -28 | -80 | $6,928,775 |
MedAdvisor (ASX:MDR) has signed its second US agreement to provide medication education programs for a top 10 pharmaceutical company.
It did not disclose the name of that company.
It will hold four, nine-month-long digital health pilot programs offering digital education to patients on any one of four different medications over the next 12 months.
Patients will be drawn from up to 4,000 US pharmacies starting in the third quarter of fiscal 2020 and the revenue attributable to MedAdvisor is about $825,000.
“These initial pilot programs represent the first material revenue from the US expansion and an important milestone in the commercialisation and scale of the US market opportunity,” the company said.
The initial program equates to 80 per cent of the total revenue from Australian health programs in fiscal 2019.
Anatara Lifesciences (ASX:ANR) says in vitro and in vivo preclinical data reported for its Gastrointestinal ReProgramming (GaRP) dietary supplement has been positive and it is confident of launching a human clinical study this year.
Anatara believes its GaRP supplement may be the “breakthrough product so desperately needed by patients suffering chronic bowel conditions”, such as irritable bowel syndrome and inflammatory bowel disease.
The company has data supporting the formulation’s ability to combat the three underlying causes of chronic bowel conditions, such as reducing gut inflammation by significantly reducing the production of pro-inflammatory proteins and promoting healing of the gut lining by increasing mucin genes.
Medlab Clinical (ASX:MDC) provided a market update, saying it made record quarterly revenue from cannabis sales, with an increase of approximately 50 per cent over the previous best quarter and 400 per cent over the previous corresponding period.
It also said the Royal North Shore Hospital (RNSH) clinical trial had been completed and it was awaiting results, but the initial feedback was encouraging.
And approximately 120 Australian doctors and 230 patients have been recruited for a trial on cancer pain drug Nanabis.
Managing director Dr Sean Hall said the nutraceuticals business was expanding into new revenue territories including the US, UK and Asia and they should see revenue flow over the next few months without material operating or capital expenditure.
“We also have licensing opportunities for our NanoCelle delivery platform,” he said.